$OPRX
OptimizeRx Corp Stock $oprx

$oprx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024043749 Filed on May 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$19.69M	$28.37M	$13.00M
YoY Change	51.43%	44.34%	-5.31%
Cost Of Revenue	$7.486M	$10.53M	$5.570M
YoY Change	34.41%	46.22%	-1.07%
Gross Profit	$12.20M	$17.84M	$7.433M
YoY Change	64.18%	43.25%	-8.25%
Gross Profit Margin	61.98%	62.89%	57.17%
Selling, General & Admin	$16.17M	$18.86M	$14.03M
YoY Change	15.2%	-29.3%	23.19%
% of Gross Profit	132.46%	105.7%	188.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.067M	$1.002M	$463.9K
YoY Change	129.99%	119.39%	-1.61%
% of Gross Profit	8.74%	5.61%	6.24%
Operating Expenses	$17.23M	$19.86M	$14.50M
YoY Change	18.88%	49.15%	22.2%
Operating Profit	-$5.029M	-$2.023M	-$7.063M
YoY Change	-28.8%	134.08%	87.8%
Interest Expense	$1.546M	-$1.336M	$665.5K
YoY Change	132.32%	-348.12%
% of Operating Profit
Other Income/Expense, Net	-$1.526M	$500.0K	$665.5K
YoY Change	-329.31%		22182300.0%
Pretax Income	-$6.555M	-$11.74M	-$6.398M
YoY Change	2.46%	3502.79%	70.1%
Income Tax	$344.0K	-$7.598M
% Of Pretax Income
Net Earnings	-$6.899M	-$4.141M	-$6.398M
YoY Change	7.84%	1170.99%	70.1%
Net Earnings / Revenue	-35.04%	-14.6%	-49.2%
Basic Earnings Per Share	-$0.38		-$0.37
Diluted Earnings Per Share	-$0.38	-$0.23	-$0.37
COMMON SHARES
Basic Shares Outstanding	18.17M shares	18.15M shares	17.10M shares
Diluted Shares Outstanding	18.17M shares		17.09M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.18M	$13.85M	$73.70M
YoY Change	-79.41%	-81.32%	-17.15%
Cash & Equivalents	$15.18M	$13.85M	$16.44M
Short-Term Investments		$0.00	$57.26M
Other Short-Term Assets	$2.390M	$3.189M	$4.015M
YoY Change	-40.47%	39.84%	-12.9%
Inventory
Prepaid Expenses
Receivables	$29.75M	$36.25M	$18.16M
Other Receivables	$1.036M	$1.036M	$0.00
Total Short-Term Assets	$48.35M	$54.33M	$95.88M
YoY Change	-49.57%	-44.88%	-14.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$153.0K	$722.3K	$143.9K
YoY Change	6.31%	425.51%	4.72%
Goodwill	$78.36M	$78.36M	$22.67M
YoY Change	245.58%	245.58%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$501.0K	$568.1K
YoY Change		11148.51%
Total Long-Term Assets	$128.0M	$129.0M	$35.81M
YoY Change	257.48%	257.71%	40.77%
TOTAL ASSETS
Total Short-Term Assets	$48.35M	$54.33M	$95.88M
Total Long-Term Assets	$128.0M	$129.0M	$35.81M
Total Assets	$176.4M	$183.4M	$131.7M
YoY Change	33.92%	36.18%	-4.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.665M	$2.227M	$1.289M
YoY Change	29.18%	43.69%	114.55%
Accrued Expenses	$7.278M	$7.976M	$2.125M
YoY Change	242.53%	206.64%	17.67%
Deferred Revenue	$905.0K	$172.0K	$735.0K
YoY Change	23.13%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.500M	$2.000M
YoY Change
Total Short-Term Liabilities	$16.77M	$17.88M	$7.606M
YoY Change	120.43%	112.98%	10.62%
LONG-TERM LIABILITIES
Long-Term Debt	$32.41M	$34.23M	$0.00
YoY Change
Other Long-Term Liabilities	$314.0K	$371.4K	$123.2K
YoY Change	154.81%	157.0%	-42.13%
Total Long-Term Liabilities	$32.41M	$34.60M	$123.2K
YoY Change	26202.85%		-42.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.77M	$17.88M	$7.606M
Total Long-Term Liabilities	$32.41M	$34.60M	$123.2K
Total Liabilities	$53.83M	$56.82M	$7.729M
YoY Change	596.48%	565.32%	9.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$71.16M	-$64.26M	-$53.09M
YoY Change	34.03%	37.62%
Common Stock	$20.00K	$19.90K	$18.33K
YoY Change	9.1%	8.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.000K	$1.741K	$1.214K
YoY Change	64.74%	43.41%
Treasury Stock Shares
Shareholders Equity	$122.5M	$126.6M	$124.0M
YoY Change
Total Liabilities & Shareholders Equity	$176.4M	$183.4M	$131.7M
YoY Change	33.92%	36.18%	-4.67%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	-$6.899M	-$4.141M	-$6.398M
YoY Change	7.84%	1170.99%	70.1%
Depreciation, Depletion And Amortization	$1.067M	$1.002M	$463.9K
YoY Change	129.99%	119.39%	-1.61%
Cash From Operating Activities	$2.118M	-$6.259M	-$86.33K
YoY Change	-2553.38%	-323.26%	-102.12%
INVESTING ACTIVITIES
Capital Expenditures	$153.0K	-$778.6K	$28.58K
YoY Change	435.34%	-537.23%	-297.38%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$26.78M	-$1.326M
YoY Change	-100.0%	46.26%	2487.11%
Cash From Investing Activities	-$153.0K	-$26.00M	-$1.549M
YoY Change	-90.12%	40.64%	2255.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$500.0K
YoY Change
Cash From Financing Activities	-$640.0K	36.19M	-$129.8K
YoY Change	393.09%	-586.47%	-150.28%
NET CHANGE
Cash From Operating Activities	$2.118M	-6.259M	-$86.33K
Cash From Investing Activities	-$153.0K	-26.00M	-$1.549M
Cash From Financing Activities	-$640.0K	36.19M	-$129.8K
Net Change In Cash	$1.325M	3.934M	-$1.765M
YoY Change	-175.07%	-117.01%	-141.31%
FREE CASH FLOW
Cash From Operating Activities	$2.118M	-$6.259M	-$86.33K
Capital Expenditures	$153.0K	-$778.6K	$28.58K
Free Cash Flow	$1.965M	-$5.481M	-$114.9K
YoY Change	-1810.03%	-308.75%	-102.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2227000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7278000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7706000	usd
CY2024Q1	oprx	Revenue Share Payable Current RevenueSharePayableCurrent	2814000	usd
CY2023Q4	oprx	Revenue Share Payable Current RevenueSharePayableCurrent	5506000	usd
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-38543
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	OptimizeRx Corporation
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1265381
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	260 Charles Street
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 302
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Waltham
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02453
CY2024Q1	dei	City Area Code CityAreaCode	248
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	651-6568
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18269823	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15177000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13852000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	371000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	480000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29748000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36253000	usd
CY2024Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1036000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1036000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2390000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3190000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	48351000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	54331000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	153000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	78357000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	78357000	usd
CY2024Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	14882000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	15198000	usd
CY2024Q1	oprx	Tradename And Customer Relationships Net Current TradenameAndCustomerRelationshipsNetCurrent	33596000	usd
CY2023Q4	oprx	Tradename And Customer Relationships Net Current TradenameAndCustomerRelationshipsNetCurrent	34198000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	527000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	573000	usd
CY2024Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	501000	usd
CY2023Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	568000	usd
CY2024Q1	oprx	Assets Noncurrent Excluding Property Plant And Equipment AssetsNoncurrentExcludingPropertyPlantAndEquipment	127863000	usd
CY2023Q4	oprx	Assets Noncurrent Excluding Property Plant And Equipment AssetsNoncurrentExcludingPropertyPlantAndEquipment	128894000	usd
CY2024Q1	us-gaap	Assets Assets	176367000	usd
CY2023Q4	us-gaap	Assets Assets	183374000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3500000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1665000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	371000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	49000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	233000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	222000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	904000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	172000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	16765000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17882000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	32413000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34231000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	314000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	371000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4337000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4337000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	53829000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	56821000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	166666667	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	166666667	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19921879	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19899679	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2024Q1	oprx	Treasury Stock Par Value TreasuryStockParValue	0.001
CY2023Q4	oprx	Treasury Stock Par Value TreasuryStockParValue	0.001
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	193677000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	190793000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71157000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64258000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	122538000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	126553000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176367000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	183374000	usd
CY2024Q1	us-gaap	Revenues Revenues	19690000	usd
CY2023Q1	us-gaap	Revenues Revenues	13003000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	7486000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	5570000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	12204000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	7433000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16166000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14032000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1067000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	464000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	17233000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	14496000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5029000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7063000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1546000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	20000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	665000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1526000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	665000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6555000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6398000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	344000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6899000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6398000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18170108	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17094676	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18170108	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17094676	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	126553000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1353000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1671000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-140000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6899000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	122538000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	126111000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1467000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2914000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-171000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6398000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	123963000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6899000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6398000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1067000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	464000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3024000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4381000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	132000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	128000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	182000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6373000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3862000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-800000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1734000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-562000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-261000	usd
CY2024Q1	oprx	Increase Decrease In Revenue Share Payable IncreaseDecreaseInRevenueSharePayable	-2692000	usd
CY2023Q1	oprx	Increase Decrease In Revenue Share Payable IncreaseDecreaseInRevenueSharePayable	-623000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-362000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-476000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	323000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	732000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	571000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2118000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-86000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	32000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	29000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	56927000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	55600000	usd
CY2024Q1	oprx	Capitalized Software Development Costs CapitalizedSoftwareDevelopmentCosts	121000	usd
CY2023Q1	oprx	Capitalized Software Development Costs CapitalizedSoftwareDevelopmentCosts	194000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-153000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1550000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	140000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	171000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	40000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	500000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-640000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-131000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1325000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1767000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13852000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18210000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15177000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16441000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1350000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	21000	usd
CY2024Q1	oprx	Number Of Us Providers NumberOfUSProviders	2000000	pure
CY2023Q4	oprx	Issued And Outstanding Share Percentage IssuedAndOutstandingSharePercentage	1	pure
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	21031000	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-8632000	usd
CY2024Q1	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	1876	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	371000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	480000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	71000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	48000	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	351000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	696000	usd
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	4471000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	4198000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	33568000	usd
CY2023	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	2021000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	904000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	172000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	172000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164000	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3229000	usd
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2444000	usd
CY2024Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	3961000	usd
CY2023Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	3015000	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	904000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	735000	usd
CY2024Q1	us-gaap	Revenues Revenues	19690000	usd
CY2023Q1	us-gaap	Revenues Revenues	13003000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	239000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	352000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	132000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	128000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	63	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	33	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	37790000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	38290000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3500000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	usd
CY2024Q1	oprx	Less Unamortized Issuance Costs LessUnamortizedIssuanceCosts	1877000	usd
CY2023Q4	oprx	Less Unamortized Issuance Costs LessUnamortizedIssuanceCosts	2059000	usd
CY2024Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	32413000	usd
CY2023Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	34231000	usd
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.141	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.16	pure
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	182	usd
CY2023Q4	oprx	Repayable Percentage RepayablePercentage	0.0125	pure
CY2023Q4	us-gaap	Fair Value Concentration Of Risk Cash And Cash Equivalents FairValueConcentrationOfRiskCashAndCashEquivalents	500000	usd
CY2024Q1	oprx	Leverage Ratio Describtion LeverageRatioDescribtion	In addition, the Company is required to make a mandatory prepayment on March 31, of each year, commencing with 2025, equivalent to Excess Cash Flow multiplied by a percentage factor of 25%, if the leverage ratio is 3.60 to 1.00 or less, 50% if the leverage ratio is greater than 3.60 to 1 or less than or equal; to 4.10 to 1.00 and 75%, if the leverage ratio is greater than 4.10 to 1.00.
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1500000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3500000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	30790000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	37790000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	62	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	25	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	196	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	187	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	114	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	66	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	45	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	608	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	61	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	547	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0675	pure
CY2024Q1	us-gaap	Lease Deposit Liability LeaseDepositLiability	54000	usd
CY2023Q1	us-gaap	Lease Deposit Liability LeaseDepositLiability	22000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	65000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	25000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	51000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	25000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	166666667	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18180482	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18158282	shares
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1741397	shares
CY2024Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	9423	shares
CY2024Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	140000	usd
CY2023Q1	us-gaap	Shares Issued SharesIssued	9502	shares
CY2023Q1	us-gaap	Life Settlement Contracts Investment Method Carrying Amount LifeSettlementContractsInvestmentMethodCarryingAmount	171000	usd
CY2024Q1	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1353000	usd
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1467000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	7479000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Weighted Average Amortization Period PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod	P1Y7M2D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	492000	usd
CY2024Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	1671000	usd
CY2023Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	2914000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	9967000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6899000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6398000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18170108	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17094676	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18170108	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17094676	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 9 – COMMITMENTS AND CONTINGENT LIABILITIES</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Litigation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Company may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are currently not a party to any material legal or administrative proceedings, and we are not aware of any pending or threatened material legal or administrative proceedings against us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Commitments</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Company enters into arrangements with partners to acquire minimum amounts of media, data or messaging capabilities. As of March 31, 2023, the Company had commitments for future minimum payments of $22.6 million that will be reflected in cost of revenues during the years from 2024 through 2028. Minimum payments are due in the remainder of 2024 and fiscal 2025, 2026, 2027 and 2028 in the amounts of $8.5 million, $8.3 million, $3.3 million, $2.4 million and $0.1 million, respectively.</p>
CY2024Q1	us-gaap	Other Commitment OtherCommitment	22600000	usd
CY2024Q1	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	8500000	usd
CY2024Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	8300000	usd
CY2024Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	3300000	usd
CY2024Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	2400000	usd
CY2024Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	100000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	344000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.052	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16700000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001448431

Files In Submission

Name	View Source	Status
0001213900-24-043749-index-headers.html	Edgar Link	pending
0001213900-24-043749-index.html	Edgar Link	pending
0001213900-24-043749.txt	Edgar Link	pending
0001213900-24-043749-xbrl.zip	Edgar Link	pending
ea0205947-10q_opti.htm	Edgar Link	pending
ea020594701ex31-1_optimizerx.htm	Edgar Link	pending
ea020594701ex31-2_optimizerx.htm	Edgar Link	pending
ea020594701ex32-1_optimizerx.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oprx-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
oprx-20240331_cal.xml	Edgar Link	unprocessable
oprx-20240331_def.xml	Edgar Link	unprocessable
oprx-20240331_lab.xml	Edgar Link	unprocessable
oprx-20240331_pre.xml	Edgar Link	unprocessable
ea0205947-10q_opti_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPRX
OptimizeRx Corp Stock $oprx

2024 Q1 Form 10-Q Financial Statement

#000121390024043749 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPRX OptimizeRx Corp Stock $oprx

2024 Q1 Form 10-Q Financial Statement

#000121390024043749 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPRX
OptimizeRx Corp Stock $oprx